OBIO
Orchestra BioMed Holdings Inc (OBIO)
Healthcare • NASDAQ • $4.04+2.80%
- Symbol
- OBIO
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $4.04
- Daily Change
- +2.80%
- Market Cap
- $241.92M
- Trailing P/E
- N/A
- Forward P/E
- -2.37
- 52W High
- $5.42
- 52W Low
- $2.20
- Analyst Target
- $12.43
- Dividend Yield
- N/A
- Beta
- 0.52
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications, such as urology or osteoarthritis; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medica…
Company websiteResearch OBIO on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.